BioRestorative Therapies Inc (BRTX)
1.365
-0.10
(-6.51%)
USD |
NASDAQ |
May 03, 16:00
1.35
-0.02
(-1.10%)
After-Hours: 20:00
BioRestorative Therapies Free Cash Flow (Quarterly): -1.844M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.843M |
| September 30, 2023 | -1.190M |
| June 30, 2023 | -1.159M |
| March 31, 2023 | -2.409M |
| December 31, 2022 | -1.833M |
| September 30, 2022 | -1.427M |
| June 30, 2022 | -1.389M |
| March 31, 2022 | -1.704M |
| December 31, 2021 | -1.145M |
| September 30, 2021 | -0.6294M |
| June 30, 2021 | -0.7418M |
| March 31, 2021 | -0.8137M |
| December 31, 2020 | -0.5721M |
| September 30, 2020 | -0.5231M |
| June 30, 2020 | -0.4204M |
| March 31, 2020 | -0.4486M |
| December 31, 2019 | -1.811M |
| September 30, 2019 | -1.717M |
| June 30, 2019 | -1.446M |
| March 31, 2019 | -1.980M |
| December 31, 2018 | -1.553M |
| September 30, 2018 | -1.353M |
| June 30, 2018 | -1.053M |
| March 31, 2018 | -1.158M |
| December 31, 2017 | -1.360M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.5092M |
| June 30, 2017 | -0.766M |
| March 31, 2017 | -1.219M |
| December 31, 2016 | -1.068M |
| September 30, 2016 | -1.236M |
| June 30, 2016 | -1.079M |
| March 31, 2016 | -1.808M |
| December 31, 2015 | -1.102M |
| September 30, 2015 | -0.7922M |
| June 30, 2015 | -0.8694M |
| March 31, 2015 | -0.8419M |
| December 31, 2014 | -0.8011M |
| September 30, 2014 | -0.8352M |
| June 30, 2014 | -0.9532M |
| March 31, 2014 | -0.8067M |
| December 31, 2013 | -0.7638M |
| September 30, 2013 | -0.4344M |
| June 30, 2013 | -0.7025M |
| March 31, 2013 | -0.7718M |
| December 31, 2012 | -1.083M |
| September 30, 2012 | -0.4509M |
| June 30, 2012 | -2.259M |
| March 31, 2012 | -0.3939M |
| December 31, 2011 | -1.116M |
| September 30, 2011 | -0.2746M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-2.409M
Minimum
Mar 2023
-0.4204M
Maximum
Jun 2020
-1.222M
Average
-1.190M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| Palatin Technologies Inc | -10.51M |
| Madrigal Pharmaceuticals Inc | -80.97M |
| Tenax Therapeutics Inc | -1.174M |
| Akero Therapeutics Inc | -48.63M |
| 89bio Inc | -34.29M |